Closing Bell: Arch Biopartners Inc down on Thursday (ARCH)

Today, Arch Biopartners Inc opened at $1.50 and closed at $1.49. prices ranged from a low of $1.44 to a high of $1.50.

Share prices dipped -1.32% from the previous day's close of $1.51.

Today across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

A total of 15,500 shares was traded during the last trading day, with total trades of 28. On average, Arch Biopartners Inc has traded 18,471 shares over 5 days and 22,999 year-to-date.

The TSX-V overall saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, in the last 12 months, Arch Biopartners Inc's shares have reduced -28.71%, while they have advanced 0.68% since the start of 2024.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $96.41 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Arch Biopartners Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..